These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3005905)

  • 1. Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat.
    Corda MG; Concas A; Porceddu ML; Sanna E; Biggio G
    Neuropharmacology; 1986 Jan; 25(1):59-62. PubMed ID: 3005905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denervation supersensitivity for benzodiazepine receptors in the rat substantia nigra.
    Biggio G; Corda MG; Concas A; Gessa GL
    Brain Res; 1981 Sep; 220(2):344-9. PubMed ID: 6269689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in nigral type II benzodiazepine recognition sites following striatonigral denervation.
    Porceddu ML; Corda MG; Sanna E; Biggio G
    Eur J Pharmacol; 1985 Jun; 112(2):265-7. PubMed ID: 2993000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes.
    Sanna E; Motzo C; Usala M; Pau D; Cagetti E; Biggio G
    J Neurochem; 1998 Jun; 70(6):2539-44. PubMed ID: 9603220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic increase in nigral t-[35S]butylbicyclophosphorothionate binding sites elicited by the degeneration of the striato-nigral GABAergic pathway: reversal by diazepam.
    Sanna E; Serra M; Pepitoni S; Biggio G
    Brain Res; 1989 Oct; 501(1):144-9. PubMed ID: 2553212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions.
    Pan HS; Penney JB; Young AB
    J Pharmacol Exp Ther; 1984 Sep; 230(3):768-75. PubMed ID: 6147405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
    Palkovits M; Lovas G; Horváth E
    Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra.
    Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
    Nature; 1983 Nov 3-9; 306(5938):57-60. PubMed ID: 6314146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that [3H]forskolin binding in the substantia nigra is intrinsic to a striatal-nigral projection: an autoradiographic study of rat brain.
    Gehlert DR; Dawson TM; Filloux FM; Sanna E; Hanbauer I; Wamsley JK
    Neurosci Lett; 1987 Jan; 73(2):114-8. PubMed ID: 3822243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA receptor binding in rat striatum: localization and effects of denervation.
    Campochiaro P; Schwarcz R; Coyle JT
    Brain Res; 1977 Nov; 136(3):501-11. PubMed ID: 922498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML; Giorgi O; Ongini E; Mele S; Biggio G
    Life Sci; 1986 Jul; 39(4):321-8. PubMed ID: 3526066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids in the substantia nigra of rats with striatal lesions produced by kainic acid.
    Korf J; Venema K
    J Neurochem; 1983 Apr; 40(4):1171-3. PubMed ID: 6834048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter receptor localizations: brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding.
    Chang RS; Tran VT; Snyder SH
    Brain Res; 1980 May; 190(1):95-110. PubMed ID: 6103733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The striatonigral GABA pathway: functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions.
    Waddington JL; Cross AJ
    Eur J Pharmacol; 1980 Oct; 67(1):27-32. PubMed ID: 6252027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in benzodiazepine and GABA receptor binding in rat brain following systemic injection of kainic acid.
    Kish SJ; Sperk G; Hornykiewicz O
    Neuropharmacology; 1983 Nov; 22(11):1303-9. PubMed ID: 6320037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and distant neuronal degeneration following intrastriatal injection of kainic acid.
    Zaczek R; Simonton S; Coyle JT
    J Neuropathol Exp Neurol; 1980 May; 39(3):245-64. PubMed ID: 6154134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution and function of DL-[3H]2-amino-4-phosphonobutyrate binding sites in the rat striatum.
    Butcher SP; Roberts PJ; Collins JF
    Brain Res; 1986 Sep; 381(2):305-13. PubMed ID: 3092992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.